FDAFDA · Food and drugs·Recall number D-0027-2022
Imipramine Pamoate Capsules 125 mg, 30-count bottle, Rx only, Manufactured for Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 UNited States. Manufactured by: Lupin Limited, Pithampur, (M.P.) 454 775 India NDC# 68180-316-06
Published October 27, 2021 · Recall initiated: October 8, 2021
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Out of specification result observed in a dissolution test at the 9-month long term stability time point.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- IMIPRAMINE PAMOATE
- Manufacturer
- Lupin Pharmaceuticals Inc.
- Distributor
- Distributed Nationwide in the USA.
- UPC
- 0368180314066
- Lot
- lot H002205, exp. date 08/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.